放宽受体-供体体型匹配以扩大心脏移植供体池
单中心回顾性分析2007年4月至2017年9月连续288例心脏移植受者,按供受体体重比(DRWR)分为偏小组(<0.7)、匹配组(0.7-1.3)和偏大组(>1.3)。偏小组术后1周充盈压最高、心脏指数最低且住院时间更长,但1年生存率在总体及LVAD桥接受者中均无显著差异。放宽体型匹配可能显著扩大供体池。
要点
- 供受体体重比<0.7的偏小匹配不影响1年生存,但早期血流动力学较差、住院时间更长。
- LVAD桥接患者中偏小匹配与匹配组的1年生存率无显著差异。
- 放宽体型匹配标准可能显著扩大心脏移植供体池。
核心结论
- 心脏移植偏小匹配影响术后早期血流动力学但不影响后期过程,且不影响1年生存。
- 放宽体型匹配可能显著扩大心脏移植供体池。
研究设计与样本
- 单中心回顾性分析,纳入2007年4月至2017年9月连续288例心脏移植患者(平均年龄53±11岁,76%男性)。
- 按供受体体重比(DRWR)分为偏小组<0.7(46例,0.61±0.05)、匹配组0.7-1.3(210例,0.94±0.16)和偏大组>1.3(32例,1.65±0.38)。
主要发现
- 三组供体左室舒张末内径(LVEDD)无显著差异(p=0.11),偏小组供受体预测心脏质量比(D/R PHM)最低(0.92±0.13)。
- 总体队列与LVAD队列1年生存率在三组间无显著差异(p=0.65和p=0.59)。
- 存活者与死亡者之间供体LVEDD及D/R PHM均无差异。
- 偏小组住院时间较匹配组长(p=0.004)。
- 偏小组术后1周充盈压最高、心脏指数最低(p=0.009、0.017、p=0.05),1个月和6个月血流动力学无临床显著差异。
关键数值与推荐
- 指南推荐供受体体重匹配在30%以内,但缺乏强证据基础,在LVAD桥接受者中亦未确立。
- 偏小匹配定义为供受体体重比<0.7,匹配为0.7-1.3,偏大为>1.3。
临床怎么用
- 在供体稀缺背景下,可考虑适当放宽供受体体型匹配标准以扩大供体池。
- 对偏小匹配受者应关注术后早期血流动力学及住院时间延长风险。
局限性
- 为单中心回顾性分析,样本量288例,结论需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The heart transplant (HT) guidelines recommendation to match recipient and donors within 30% of body weight lacks a strong evidence base and is not well established in patients bridged to transplant with left ventricular assist devices (LVAD). In light of the scarcity of donor hearts, we investigated the effect of size mismatch on hemodynamics, one-year survival and length of stay (LOS) following HT. METHODS: Single-center retrospective analysis of consecutive HT patients from April 2007 to September 2017. Recipients were divided into 3 cohorts based on donor-to-recipient weight ratio (DRWR): (1) undersized (<0.7), (2) size-matched, (0.7-1.3); (3) oversized (>1.3). RESULTS: 288 consecutive patients were identified (mean age 53 ± 11 years; 76% male), 46 were undersized (0.61 ± 0.05), 210 size-matched (0.94 ± 0.16), and 32 oversized (1.65 ± 0.38). There was no significant difference in donor left ventricular end diastolic diameter (LVEDD) between the 3 groups (p = 0.11). The donor/recipient (D/R) predicted heart mass (PHM) was lowest in the undersized group (0.92 ± 0.13). There were no significant differences in 1-year survival in the overall and LVAD cohort (p = 0.65 and 0.59, respectively). Neither donor LVEDD nor D/R PHM differed among survivors or non-survivors. LOS was longer in the undersized group than the size-matched cohort (p = 0.004). The undersized group had hearts with the highest filling pressures and lowest cardiac index at 1 week among the remaining groups (p = 0.009, 0.017, and p = 0.05, respectively). There were no clinically significant differences in hemodynamics at 1 or 6 months. CONCLUSIONS: HT undersizing affects hemodynamics early but not later in the course and does not impact 1-year survival. The liberalization of size matching may increase the HT donor pool significantly.
引用
- Holzhauser L, Imamura T, Bassi N, et al. Increasing heart transplant donor pool by liberalization of size matching. J Heart Lung Transplant. 2019. PMID: 31672219. doi:10.1016/j.healun.2019.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。